ArticleJournal of robotic surgery2026
Procedure-specific outcomes of robotic versus laparoscopic Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch across a decade of MBSAQIP adoption.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic adoption in metabolic and bariatric surgery has increased, but its procedure-specific short-term outcomes remain uncertain. This study compared robotic and laparoscopic Roux-en-Y gastric bypass (RYGB) and biliopancreatic diversion with duodenal switch (BPD-DS) over a decade. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database was queried for primary RYGB and BPD-DS performed from 2015 to 2024. Missing data were addressed using multiple imputation followed by stabilized inverse probability of treatment weighting. Propensity-score and outcome models were fitted separately within four predefined procedure-period strata: RYGB 2015-2019, RYGB 2020-2024, BPD-DS 2015-2019, and BPD-DS 2020-2024. Thirty-day outcomes were estimated within each stratum, with Benjamini-Hochberg false-discovery-rate adjustment applied across the modeled comparisons. The analysis included 411,155 patients: 87,028 R-RYGB, 307,420 L-RYGB, 5,283 R-BPD-DS, and 11,424 L-BPD-DS. Robotic utilization increased from 8.6% to 44.0% for RYGB and from 28.2% to 50.3% for BPD-DS. For RYGB, the robotic approach was associated with higher readmission in both periods (OR 1.23 and 1.19), lower odds of serious complications (OR 0.84 and 0.87), and longer operative duration (mean differences 39.83 and 26.17 min). For BPD-DS, robotic surgery was associated with higher readmission in both periods (OR 1.38 and 1.25), higher intervention in 2015-2019 (OR 1.65), and longer operative duration (mean differences 87.49 and 40.85 min). BPD-DS estimates were less precise, and some associations attenuated in the complete-case sensitivity analysis. Robotic utilization increased substantially but was associated with longer operative duration and higher readmission for both procedures, without a clear overall 30-day safety advantage. BPD-DS findings were less precise and should be considered exploratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.